151 related articles for article (PubMed ID: 33131543)
1. Hearing and Other Neurologic Problems.
Landier W; Cohn RJ; van den Heuvel-Eibrink MM
Pediatr Clin North Am; 2020 Dec; 67(6):1219-1235. PubMed ID: 33131543
[TBL] [Abstract][Full Text] [Related]
2. Ototoxicity and cancer therapy.
Landier W
Cancer; 2016 Jun; 122(11):1647-58. PubMed ID: 26859792
[TBL] [Abstract][Full Text] [Related]
3. Chemotherapy-Induced Peripheral Neuropathy in Long-term Survivors of Childhood Cancer: Clinical, Neurophysiological, Functional, and Patient-Reported Outcomes.
Kandula T; Farrar MA; Cohn RJ; Mizrahi D; Carey K; Johnston K; Kiernan MC; Krishnan AV; Park SB
JAMA Neurol; 2018 Aug; 75(8):980-988. PubMed ID: 29799906
[TBL] [Abstract][Full Text] [Related]
4. Endocrine Health in Childhood Cancer Survivors.
van Santen HM; Chemaitilly W; Meacham LR; Tonorezos ES; Mostoufi-Moab S
Pediatr Clin North Am; 2020 Dec; 67(6):1171-1186. PubMed ID: 33131540
[TBL] [Abstract][Full Text] [Related]
5. Recommendations for ototoxicity surveillance for childhood, adolescent, and young adult cancer survivors: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group in collaboration with the PanCare Consortium.
Clemens E; van den Heuvel-Eibrink MM; Mulder RL; Kremer LCM; Hudson MM; Skinner R; Constine LS; Bass JK; Kuehni CE; Langer T; van Dalen EC; Bardi E; Bonne NX; Brock PR; Brooks B; Carleton B; Caron E; Chang KW; Johnston K; Knight K; Nathan PC; Orgel E; Prasad PK; Rottenberg J; Scheinemann K; de Vries ACH; Walwyn T; Weiss A; Am Zehnhoff-Dinnesen A; Cohn RJ; Landier W;
Lancet Oncol; 2019 Jan; 20(1):e29-e41. PubMed ID: 30614474
[TBL] [Abstract][Full Text] [Related]
6. Renal and Hepatic Health After Childhood Cancer.
Ehrhardt MJ; Skinner R; Castellino SM
Pediatr Clin North Am; 2020 Dec; 67(6):1203-1217. PubMed ID: 33131542
[TBL] [Abstract][Full Text] [Related]
7. Emerging and established therapies for chemotherapy-induced ototoxicity.
Guthrie OW; Spankovich C
J Cancer Surviv; 2023 Feb; 17(1):17-26. PubMed ID: 36637631
[TBL] [Abstract][Full Text] [Related]
8. Cardiovascular and Pulmonary Challenges After Treatment of Childhood Cancer.
Visscher H; Otth M; Feijen EAML; Nathan PC; Kuehni CE
Pediatr Clin North Am; 2020 Dec; 67(6):1155-1170. PubMed ID: 33131539
[TBL] [Abstract][Full Text] [Related]
9. Pain and neuropathy in cancer survivors. Surgery, radiation, and chemotherapy can cause pain; research could improve its detection and treatment.
Polomano RC; Farrar JT
Am J Nurs; 2006 Mar; 106(3 Suppl):39-47. PubMed ID: 16481851
[No Abstract] [Full Text] [Related]
10. Challenges Evaluating Chemotherapy-Induced Peripheral Neuropathy in Childhood Cancer Survivors.
Mohrmann C; Armer J; Hayashi RJ
J Pediatr Oncol Nurs; 2017; 34(2):106-114. PubMed ID: 27251891
[TBL] [Abstract][Full Text] [Related]
11. Endocrine Sequelae in Childhood Cancer Survivors.
George SA; Effinger KE; Meacham LR
Endocrinol Metab Clin North Am; 2020 Dec; 49(4):565-587. PubMed ID: 33153668
[TBL] [Abstract][Full Text] [Related]
12. Troublesome symptoms in cancer survivors: fatigue, insomnia, neuropathy, and pain.
Pachman DR; Barton DL; Swetz KM; Loprinzi CL
J Clin Oncol; 2012 Oct; 30(30):3687-96. PubMed ID: 23008320
[TBL] [Abstract][Full Text] [Related]
13. Reproductive Complications in Childhood Cancer Survivors.
van Santen HM; van de Wetering MD; Bos AME; Vd Heuvel-Eibrink MM; van der Pal HJ; Wallace WH
Pediatr Clin North Am; 2020 Dec; 67(6):1187-1202. PubMed ID: 33131541
[TBL] [Abstract][Full Text] [Related]
14. Challenges in ototoxicity monitoring in the pediatric oncology population.
Bass JK; Bhagat SP
J Am Acad Audiol; 2014 Sep; 25(8):760-74; quiz 782-3. PubMed ID: 25380122
[TBL] [Abstract][Full Text] [Related]
15. Late effects in survivors of bone tumors.
Mosher RB; McCarthy BJ
J Pediatr Oncol Nurs; 1998 Apr; 15(2):72-84; quiz 85-9. PubMed ID: 9597816
[TBL] [Abstract][Full Text] [Related]
16. Drug-induced tinnitus and other hearing disorders.
Seligmann H; Podoshin L; Ben-David J; Fradis M; Goldsher M
Drug Saf; 1996 Mar; 14(3):198-212. PubMed ID: 8934581
[TBL] [Abstract][Full Text] [Related]
17. [Drugs ototoxicity. Part II. Loop diuretics, nonsteroidal anti-inflammatory drugs, antineoplastic and antimalarial drugs ].
Wrześniok D; Buszman E; Matusiński B
Wiad Lek; 2003; 56(7-8):369-74. PubMed ID: 14969167
[TBL] [Abstract][Full Text] [Related]
18. Cancer survivors treated with platinum-based chemotherapy affected by ototoxicity and the impact on quality of life: a narrative synthesis systematic review.
Pearson SE; Taylor J; Patel P; Baguley DM
Int J Audiol; 2019 Nov; 58(11):685-695. PubMed ID: 31545660
[No Abstract] [Full Text] [Related]
19. Cis-platinum ototoxicity after radiation treatment: an animal model.
Baranak CC; Wetmore RF; Packer RJ
J Neurooncol; 1988 Nov; 6(3):261-7. PubMed ID: 3225645
[TBL] [Abstract][Full Text] [Related]
20. Neurologic complications of cancer therapy.
Plotkin SR; Wen PY
Neurol Clin; 2003 Feb; 21(1):279-318, x. PubMed ID: 12690653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
